Literature DB >> 2386584

Thyroxine replacement treatment and osteoporosis.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2386584      PMCID： PMC1662763          DOI： 10.1136/bmj.300.6731.1074-b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

Review 1.  Thyroxine replacement treatment and osteoporosis.

Authors:  J A Franklyn; M C Sheppard
Journal:  BMJ       Date:  1990-03-17

2.  Premyxoedema and coronary-artery disease.

Authors:  P S Fowler; J Swale
Journal:  Lancet       Date:  1967-05-20       Impact factor: 79.321

3.  Hypercholesterolaemia in borderline hypothyroidism. Stage of premyxoedema.

Authors:  P B Fowler; J Swale; H Andrews
Journal:  Lancet       Date:  1970-09-05       Impact factor: 79.321

4.  Exaggerated responsiveness to thyrotrophin releasing hormone: a risk factor in women with coronary artery disease.

Authors:  J W Dean; P B Fowler
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-25

5.  Association between exaggerated responsiveness to thyrotrophin-releasing hormone and hypercholesterolaemia.

Authors:  J Alaghband-Zadeh; G D Carter; J R Daly; P B Fowler; T W Greenwood
Journal:  Lancet       Date:  1977-11-12       Impact factor: 79.321

6.  Raised serum thyrotrophin in women with peripheral arterial disease.

Authors:  J Powell; J A Zadeh; G Carter; R M Greenhalgh; P B Fowler
Journal:  Br J Surg       Date:  1987-12       Impact factor: 6.939
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.